Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy
María Stefanía Infante, David Nemirovsky, Sean M. Devlin, Susan DeWolf, Roni Tamari, Parastoo B. Dahi, Yeon Joo Lee, David J. Chung, Ioannis Politikos, Juliet N. Barker, Sergio Giralt, N. Esther Babady, Lakshmi V. Ramanathan, Genovefa A. Papanicolaou, Susan K. Seo, Mini Kamboj, Miguel‐Angel Perales, Gunjan L. Shah
Topics & Concepts
MedicineHematopoietic stem cell transplantationInterquartile rangeOdds ratioTransplantationInternal medicineChimeric antigen receptorCoronavirus disease 2019 (COVID-19)TocilizumabImmunologyDiseaseCancerImmunotherapyInfectious disease (medical specialty)CAR-T cell therapy researchSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impacts